US SB1250 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 20 2023 - 25% progression
Action: 2023-04-20 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 20 2023 - 25% progression
Action: 2023-04-20 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Title
Drug-price Transparency for Consumers Act of 2023
Sponsors
Sen. Richard Durbin [D-IL] | Sen. Chuck Grassley [R-IA] | Sen. Angus King [I-ME] | Sen. Mike Braun [R-IN] |
Sen. Richard Blumenthal [D-CT] | Sen. J.D. Vance [R-OH] | Sen. Tammy Baldwin [D-WI] | Sen. Sherrod Brown [D-OH] |
Sen. Tina Smith [D-MN] |
History
Date | Chamber | Action |
---|---|---|
2023-04-20 | Senate | Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S1297; text: CR S1297-1298) |
Same As/Similar To
HB5958 (Same As) 2023-10-25 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/senate-bill/1250/all-info |
Text | https://www.congress.gov/118/bills/s1250/BILLS-118s1250is.pdf |